Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 131 publications
Spontaneous Coronary Artery Dissection and Takotsubo Syndrome: Converging Mechanisms, Diagnostic Pitfalls, and a Unified Clinical Algorithm.
Journal: Journal of clinical medicine
Published: June 23, 2026
The pharmacology and clinical evidence for the use of dual versus single antiplatelet therapy.
Journal: Expert review of clinical pharmacology
Published: January 06, 2026
Impact of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition on Platelet Reactivity in Patients with Atherosclerotic Cardiovascular Disease: A Pooled Analysis of Two Randomized Double-blind Placebo-controlled Studies.
Journal: Thrombosis and haemostasis
Published: October 10, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated Participants.
Journal: Clinical pharmacology and therapeutics
Published: April 17, 2025
Cangrelor in Patients With Cardiogenic Shock or Cardiac Arrest.
Journal: JACC. Cardiovascular interventions
Published: January 16, 2025
Switching Platelet P2Y12 Receptor Inhibiting Therapies.
Journal: Interventional cardiology clinics
Published: December 14, 2024
Switching from cangrelor to oral P2Y12 inhibitors: a focused review on drug-drug interactions.
Journal: Expert opinion on drug metabolism & toxicology
Published: October 16, 2024
International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update.
Journal: JACC. Cardiovascular interventions
Published: July 03, 2024
P2Y12 Inhibition in Patients Requiring Oral Anticoagulation After Percutaneous Coronary Intervention: The SWAP-AC-2 Study.
Journal: JACC. Cardiovascular interventions
Published: February 26, 2024
Clopidogrel-Mediated P2Y12 Inhibition According to Renal Function in Patients With Diabetes Mellitus and CAD.
Journal: JACC. Basic to translational science
Published: October 31, 2023
Last Updated: 09/26/2026